Herbas VPB

Print
EN | LT
LT - MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES
EN - MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 31/12 (2018.01)
C07D 239/54 (2006.01)
C07F 7/18 (2006.01)
A61P 35/00 (2018.01)
C07D 239/54 (2013.01)
C07F 9/6512 (2006.01)
C07F 9/6512 (2013.01)
C07F 9/6561 (2006.01)
C07H 21/02 (2013.01)
C07H 21/02 (2006.01)
A61K 9/00 (2006.01)
C07F 9/65616 (2013.01)
A61K 9/1271 (2013.01)
A61K 9/08 (2006.01)
A61K 9/0019 (2013.01)
A61K 9/127 (2006.01)
C12N 15/88 (2013.01)
A61K 31/513 (2006.01)
C12N2310/14 (2013.01)
A61K 31/713 (2006.01)
C12N 15/113 (2013.01)
A61K 48/00 (2006.01)
C12N2310/323 (2013.01)
A61P 31/12 (2006.01)
C12N2310/322 (2013.01)
A61P 35/00 (2006.01)
Y02P 20/55 (2015.11)
C12N 15/00 (2006.01)
C12N 15/88 (2006.01)
C12N 15/113 (2010.01)
European patent
(11) Number of the document 3643706
(13) Kind of document T
(96) European patent application number 18817223.3
Date of filing the European patent application 2018-06-14
(97) Date of publication of the European application 2020-04-29
(45) Date of publication and mention of the grant of the patent 2023-11-15
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/JP2018/022663
Date 2018-06-14
PCT application publication
(87) Number WO 2018/230624
Date 2018-12-20
Priority applications
(30) Number Date Country code
2017118572 2017-06-16 JP
Inventors
(72)
TAKAHASHI Yoshinori , JP
SUZUKI Yuta , JP
Grantee
(73) Eisai R&D Management Co., Ltd. , 4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, JP
Title
(54) MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES
  MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES